Clinical Trials Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Jul 16, 2021; 9(20): 5479-5489
Published online Jul 16, 2021. doi: 10.12998/wjcc.v9.i20.5479
Table 1 Baseline characteristics of patients, procedure time and total propofol dosages
CharacteristicWNJT group, n = 49Nasal cannula group, n = 52P value
Age (yr)37.89 ± 13.737.5 ± 12.50.892
Height (m)1.7 ± 0.11.7 ± 0.10.293
Weight (kg)100.7 ± 17.096.4 ± 18.20.217
Sex (M/F)19/3016/360.398
Body mass index (kg/m2)35.6 ± 4.834.7 ± 4.10.316
Baseline SpO2 (%)97.1 ± 1.597.1 ± 1.60.982
ASA physical status grade (I/II)22/2723/290.946
Procedure times (min)4.6 ± 0.94.8 ± 0.40.065
Total propofol dosages (mg)229.4 ± 41.7210.2 ± 45.40.030
Table 2 The lowest pulse oxygen saturation, interventions related to hypoxemia and adverse events
WNJT group, n = 49Nasal cannula group, n = 52P value
Lowest SpO2 during gastroscopy95.5 ± 4.390.0 ± 7.00.000
Airway opening maneuvers7 (14.3)36 (69.2)0.000
Facemask ventilation0 (0)4 (7.7)0.118
Body movement7 (14.3)5 (9.6)0.468
Cough5 (10.2)4 (7.7)0.926
Epistaxis (0/1/2/3)0/2/1/0 (6.1)0/0/0/0 (0)0.111
Sore throat2 (4.1)1 (1.9)0.610
Table 3 Satisfaction of physicians, anesthetists and patients

WNJT group, n = 49
Nasal cannula group, n = 52
P values
Good
Fair
Poor
Good
Fair
Poor
Physicians49 (100)0 (0)0 (0)46 (88.5)5 (9.6)1 (1.9)0.015
Anesthetists46 (93.9)2 (4.1)1(2.0)38 (73.1)12 (23.1)2 (3.8)0.006
Patients49 (100)0 (0)0(0)52 (100)0 (0)0 (0)1.000